PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
115.10%
Some net income increase while CRON.TO is negative at -89.66%. John Neff would see a short-term edge over the struggling competitor.
43.28%
Some D&A expansion while CRON.TO is negative at -48.77%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
104.01%
Well above CRON.TO's 98.06% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-83.70%
Negative yoy SBC while CRON.TO is 204.55%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
7.50%
Slight usage while CRON.TO is negative at -365.41%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
414.52%
AR growth is negative or stable vs. CRON.TO's 1214.06%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
47.56%
Inventory shrinking or stable vs. CRON.TO's 155.67%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-212.34%
Both negative yoy AP, with CRON.TO at -256.81%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-146.71%
Both reduce yoy usage, with CRON.TO at -144.17%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-138.36%
Negative yoy while CRON.TO is 85.21%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
14.93%
Some CFO growth while CRON.TO is negative at -166.49%. John Neff would note a short-term liquidity lead over the competitor.
24.00%
Lower CapEx growth vs. CRON.TO's 93.78%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
99.98%
Acquisition spending well above CRON.TO's 99.99%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
103.51%
Less growth in investment purchases vs. CRON.TO's 86108.08%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-1.98%
Both yoy lines are negative, with CRON.TO at -50.99%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
148.68%
We have some outflow growth while CRON.TO is negative at -383.32%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
173.00%
Investing outflow well above CRON.TO's 182.53%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-1003.21%
Both yoy lines negative, with CRON.TO at -98.96%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-387.36%
Negative yoy issuance while CRON.TO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.